Gut bacteria may boost liver cancer treatment before surgery
NCT ID NCT07306481
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 24 times
Summary
This study explores whether taking a probiotic (Lactobacillus reuteri) before surgery, alongside standard immunotherapy, can help liver cancer patients recover better and live longer. Forty adults with resectable liver cancer will be randomly assigned to receive either the probiotic plus immunotherapy or immunotherapy alone before their operation. Researchers will track liver function, complications, and survival over two years to see if the probiotic makes a difference.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.